INMNasdaqPharmaceutical PreparationsFiscal year ends June 30
InMed Pharmaceuticals Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 9, 2026
$1.37+0.05 (+3.44%)
Close on Oct 19, 2026
- Market cap
- $6.42M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
49.1%
3M of 5M shares
Institutional holders
20
13 new, 2 sold out
Net institutional buying
2M
In Q2 2026
Insider trades, 12 months
37 buys · 0 sales
Net bought $1.27M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Daniel Schneeberger | 943,668 | 17.20% | 13G (passive) amendment | Sep 30, 2026 |
| YA II PN, Ltd. | 80,372 | 9.99% | 13G (passive) | Dec 13, 2024 |
| Vivo Opportunity Fund Holdings, L.P. | 718,444 | 21.70% | 13D (active) | May 19, 2026 |
| William Blank | 325,000 | 9.80% | 13G (passive) | May 19, 2026 |
| Sabby Volatility Warrant Master Fund, Ltd. | 280,138 | 9.90% | 13G (passive) | Dec 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of INM | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 800,000 | 14.56% | $1.24M | New | 0.06% |
| Vivo Capital, LLC | 798,377 | 14.53% | $1.24M | New | 0.11% |
| Squadron Capital Management LLC | 325,000 | 5.92% | $503.75K | New | 0.16% |
| Ikarian Capital, LLC | 245,025 | 4.46% | $379.79K | New | 0.04% |
| Ursa Fund Management, LLC | 125,800 | 2.29% | $194.99K | New | 0.02% |
| Suvretta Capital Management, LLC | 100,000 | 1.82% | $155.00K | New | 0.00% |
| Boothbay Fund Management, LLC | 74,244 | 1.35% | $115.08K | New | 0.00% |
| Sabby Management, LLC | 44,970 | 0.82% | $69.70K | −175,290 | 0.06% |
| Jane Street Group, LLC | 43,078 | 0.78% | $66.77K | New | 0.00% |
| VR Adviser, LLC | 32,685 | 0.59% | $50.66K | New | 0.00% |
| Citadel Advisors LLC | 26,084 | 0.47% | $40.43K | −20,889 | 0.00% |
| Seven Grand Managers, LLC | 25,000 | 0.46% | $38.75K | New | 0.00% |
| Scientech Research LLC | 15,461 | 0.28% | $23.97K | New | 0.02% |
| Crestwood Advisors Group LLC | 14,900 | 0.27% | $23.10K | New | 0.00% |
| Two Sigma Securities, LLC | 10,945 | 0.20% | $16.97K | −7,773 | 0.00% |
| Stratos Wealth Partners, LTD. | 10,760 | 0.20% | $16.68K | New | 0.00% |
| Private Wealth Management Group, LLC | 5,000 | 0.09% | $7.75K | – | 0.00% |
| SBI Securities Co., Ltd. | 300 | 0.01% | $465 | – | 0.00% |
| Banque Cantonale Vaudoise | 6 | 0.00% | $1.00K | – | 0.00% |
| Federation des caisses Desjardins du Quebec | 2 | 0.00% | $4 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 20 | 3M | 49.1% | 13 / 0 | 3 / 2 | 3M | 0M |
| Q1 2026 | 9 | 0M | 5.8% | 4 / 2 | 0 / 2 | 0M | 0M |
| Q4 2025 | 7 | 0M | 4.1% | 3 / 0 | 1 / 4 | 0M | 0M |
| Q3 2025 | 9 | 0M | 5.5% | 5 / 1 | 0 / 3 | 0M | 0M |
| Q2 2025 | 7 | 0M | 0.2% | 2 / 1 | 0 / 0 | 0M | 0M |
| Q1 2025 | 5 | 0M | 0.1% | 2 / 0 | 1 / 2 | 0M | 0M |
| Q4 2024 | 5 | 0M | 0.9% | 5 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of INM | Value | % of fund | As of |
|---|---|---|---|---|---|
| Blackstone Alternative Multi-Strategy Fund | 6,495 | 0.12% | $10.07K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Eric A. Adams | President & CEO, Director | 58,894 | 1.07% | Dec 19, 2025 |
| Netta Jagpal | Chief Financial Officer | – | – | Dec 19, 2025 |
| Shane Aaron Johnson | Sr VP & General Manager | 583,023 | 10.61% | Dec 19, 2025 |
| Michael Woudenberg | Chief Operating Officer | 530 | 0.01% | Dec 19, 2025 |
| Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | 1,273 | 0.02% | Dec 19, 2025 |
| John Steven Bathery | Director | – | – | Dec 19, 2025 |
| Andrew Hull | Director | 38,258 | 0.70% | Dec 19, 2025 |
| Nicole Lemerond | Director | – | – | Dec 19, 2025 |
| Neil A. Klompas | Director | – | – | Dec 19, 2025 |
| Janet P. Grove | Director | – | – | Dec 23, 2024 |
| Bryan T. Baldasare | Director | – | – | Dec 23, 2024 |
| ADAR1 Capital Management, LLC | 10% owner | 801,000 | 14.58% | Sep 16, 2026 |
| Daniel Schneeberger | 10% owner | 892,101 | 16.24% | Sep 16, 2026 |
| Vivo Opportunity Fund Holdings, L.P. | 10% owner | 541,752 | 9.86% | Jul 16, 2026 |
| Vivo Opportunity Cayman, LLC | 10% owner | – | – | Jul 16, 2026 |
| Vivo Opportunity, LLC | 10% owner | 797,530 | 14.52% | Jul 16, 2026 |
| Vivo Opportunity Cayman Fund, L.P. | 10% owner | 818,076 | 14.89% | Jul 16, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Daniel Schneeberger 10% owner | Sep 16, 2026 | Buy | +8,340 | $1.29 | $10.76K | 892,101 |
| Daniel Schneeberger 10% owner | Sep 15, 2026 | Buy | +54,256 | $1.30 | $70.53K | 883,761 |
| Daniel Schneeberger 10% owner | Sep 14, 2026 | Buy | +28,505 | $1.29 | $36.77K | 829,505 |
| Vivo Opportunity Cayman Fund, L.P. 10% owner | Jul 16, 2026 | Buy | +19 | $1.55 | $29 | 743,057 |
| Vivo Opportunity Cayman Fund, L.P. 10% owner | Jul 16, 2026 | Buy | +2 | $1.55 | $3 | 75,019 |
| ADAR1 Capital Management, LLC 10% owner | Jul 15, 2026 | Buy | +1,000 | $1.56 | $1.56K | 801,000 |
| Vivo Opportunity Cayman Fund, L.P. 10% owner | Jul 15, 2026 | Buy | +13,761 | $1.55 | $21.33K | 743,038 |
| Vivo Opportunity Cayman Fund, L.P. 10% owner | Jul 15, 2026 | Buy | +1,389 | $1.55 | $2.15K | 75,017 |
| Vivo Opportunity Cayman Fund, L.P. 10% owner | Jul 14, 2026 | Buy | +4,882 | $1.55 | $7.57K | 729,277 |
| Vivo Opportunity Cayman Fund, L.P. 10% owner | Jul 14, 2026 | Buy | +493 | $1.55 | $764 | 73,628 |
| Vivo Opportunity, LLC 10% owner | Jul 2, 2026 | Buy | +1,460 | $1.55 | $2.26K | 724,395 |
| Vivo Opportunity, LLC 10% owner | Jul 2, 2026 | Buy | +147 | $1.55 | $228 | 73,135 |
| Vivo Opportunity, LLC 10% owner | Jul 1, 2026 | Buy | +3,946 | $1.55 | $6.12K | 722,935 |
| Vivo Opportunity, LLC 10% owner | Jul 1, 2026 | Buy | +398 | $1.55 | $617 | 72,988 |
| Vivo Opportunity, LLC 10% owner | Jun 30, 2026 | Buy | +55 | $1.54 | $85 | 72,590 |
| Vivo Opportunity, LLC 10% owner | Jun 30, 2026 | Buy | +545 | $1.54 | $839 | 718,989 |
| Vivo Opportunity, LLC 10% owner | Jun 8, 2026 | Buy | +29,518 | $1.52 | $44.87K | 718,444 |
| Vivo Opportunity, LLC 10% owner | Jun 8, 2026 | Buy | +2,982 | $1.52 | $4.53K | 72,535 |
| Vivo Opportunity, LLC 10% owner | Jun 5, 2026 | Buy | +5,045 | $1.57 | $7.92K | 69,553 |
| Vivo Opportunity, LLC 10% owner | Jun 5, 2026 | Buy | +49,966 | $1.57 | $78.45K | 688,926 |
| Vivo Opportunity, LLC 10% owner | Jun 4, 2026 | Buy | +618 | $1.57 | $970 | 64,508 |
| Vivo Opportunity, LLC 10% owner | Jun 4, 2026 | Buy | +6,125 | $1.57 | $9.62K | 638,960 |
| Vivo Opportunity, LLC 10% owner | Jun 3, 2026 | Buy | +714 | $1.55 | $1.11K | 63,890 |
| Vivo Opportunity, LLC 10% owner | Jun 3, 2026 | Buy | +7,069 | $1.55 | $10.96K | 632,835 |
| Vivo Opportunity, LLC 10% owner | Jun 2, 2026 | Buy | +2,095 | $1.52 | $3.18K | 63,176 |
| Vivo Opportunity, LLC 10% owner | Jun 2, 2026 | Buy | +20,753 | $1.52 | $31.54K | 625,766 |
| Vivo Opportunity, LLC 10% owner | Jun 1, 2026 | Buy | +1,498 | $1.55 | $2.32K | 61,081 |
| Vivo Opportunity, LLC 10% owner | Jun 1, 2026 | Buy | +14,838 | $1.55 | $23.00K | 605,013 |
| Vivo Opportunity, LLC 10% owner | May 29, 2026 | Buy | +1,632 | $1.57 | $2.56K | 59,583 |
| Vivo Opportunity, LLC 10% owner | May 29, 2026 | Buy | +16,164 | $1.57 | $25.38K | 590,175 |
| Vivo Opportunity, LLC 10% owner | May 21, 2026 | Buy | +3,118 | $1.69 | $5.27K | 57,951 |
| Vivo Opportunity, LLC 10% owner | May 21, 2026 | Buy | +30,882 | $1.69 | $52.19K | 574,011 |
| Vivo Opportunity, LLC 10% owner | May 20, 2026 | Buy | +5,154 | $1.56 | $8.04K | 54,833 |
| Vivo Opportunity, LLC 10% owner | May 20, 2026 | Buy | +51,056 | $1.56 | $79.65K | 543,129 |
| Daniel Schneeberger 10% owner | May 19, 2026 | Buy | +200,000 | $1.50 | $300.00K | 800,000 |
| Daniel Schneeberger 10% owner | May 19, 2026 | Buy | +200,000 | $1.56 | $312.00K | 600,000 |
| Daniel Schneeberger 10% owner | May 19, 2026 | Buy | +68,551 | $1.60 | $109.68K | 400,000 |
| Alexandra Diane Janet Mancini – | Jul 31, 2024 | Sale | −240 | $0.18 | $43 | 0 |
| Andrew Hull Director | Feb 21, 2024 | Buy | +37,500 | $0.39 | $14.63K | 38,258 |
| Eric A. Adams President & CEO, Director | Feb 20, 2024 | Buy | +41,600 | $0.36 | $14.98K | 43,959 |
| Eric A. Adams President & CEO, Director | Apr 14, 2022 | Buy | +14,160 | $0.89 | $12.60K | 59,003 |
| Eric A. Adams President & CEO, Director | Apr 13, 2022 | Buy | +8,560 | $0.85 | $7.28K | 44,843 |
| Bruce Colwill CFO | Jan 24, 2022 | Buy | +5,000 | $1.09 | $5.45K | 11,515 |
| Shane Aaron Johnson SVP, GM of BayMedica LLC | Jan 6, 2022 | Buy | +8,500 | $1.26 | $10.71K | 304,595 |
| Shane Aaron Johnson SVP, GM of BayMedica LLC | Dec 30, 2021 | Buy | +8,093 | $1.33 | $10.76K | 296,095 |
| Shane Aaron Johnson SVP, GM of BayMedica LLC | Nov 15, 2021 | Buy | +5,000 | $1.37 | $6.85K | 288,002 |
| Eric A. Adams President & CEO, Director | Sep 29, 2021 | Buy | +8,800 | $1.73 | $15.22K | 36,283 |
| Eric A. Adams President & CEO, Director | Sep 28, 2021 | Buy | +11,400 | $1.75 | $19.95K | 27,483 |
| Bruce Colwill CFO | Sep 28, 2021 | Buy | +5,000 | $1.77 | $8.85K | 6,515 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.